Loading data
SMCINasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 39.06 bn USD | 21.97 bn USD | 14.99 bn USD | 7.12 bn USD | 5.2 bn USD |
| Cost of revenue | 34.84 bn USD | 19.54 bn USD | 12.93 bn USD | 5.84 bn USD | 4.4 bn USD |
| Gross profit | 4.23 bn USD | 2.43 bn USD | 2.06 bn USD | 1.28 bn USD | 800 m USD |
| Research and development expense | 771.23 m USD | 636.55 m USD | 463.55 m USD | 307.26 m USD | 272.27 m USD |
| Operating profit | 2.77 bn USD | 1.25 bn USD | 1.21 bn USD | 761.14 m USD | 335.17 m USD |
| Interest expense | — | — | — | 10.49 m USD | 6.41 m USD |
| Income tax expense | 556.33 m USD | 156.85 m USD | 63.29 m USD | 110.67 m USD | 52.88 m USD |
| Net income (reported basis) | 2.23 bn USD | 1.05 bn USD | 1.15 bn USD | 640 m USD | 285 m USD |
| Net income attributable to common shareholders | 2.2 bn USD | 1.05 bn USD | 1.15 bn USD | 640 m USD | 285.16 m USD |
| Basic earnings per share | 3.65 USD/share | 1.77 USD/share | 2.07 USD/share | 1.21 USD/share | 0.55 USD/share |
| Diluted earnings per share | 3.26 USD/share | 1.68 USD/share | 1.92 USD/share | 1.14 USD/share | 0.53 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.